← All Sponsors
SPONSOR

Ono Pharmaceutical Co. Ltd

Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2
Conditions studied: Relapsed or Refractory T Cell LymphomaPan-tumor
NCT05079282 Phase 1
Recruiting

Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

Relapsed or Refractory T Cell Lymphoma
United States View Trial →
NCT04566380 Phase 2
Recruiting

ONO-4538 Phase II Rollover Study (ONO-4538-98)

Pan-tumor
Japan, South Korea, Taiwan View Trial →